Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01506518 · ClinicalTrials.gov registry record
Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular Dystrophy
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 60
- Enrollment target
NCT01506518 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 60 participants.
The verdict
NCT01506518 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 60 participants
- Enrollment target
Study Summary
This is a pilot clinical trial to assess the ability of a new ultrasound-based imaging method, Double-Push Acoustic Radiation Force (DP ARF) ultrasound, to monitor the progression of Duchenne muscular dystrophy. The hypothesis being tested is that DP ARF ultrasound delineates changes in muscle composition and function in individual dystrophic muscles, from early through late stages of disease development, that correlate to time to loss of ambulation in patient volunteers.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 60 participants |
| Start Date | 2012-01 |
| Est. Completion | 2020-05-31 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01506518
The ClinicalTrials.gov registry entry for NCT01506518 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01506518 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01506518 about?
NCT01506518 is a clinical study titled "Double Push Acoustic Radiation Force (DP ARF) Ultrasound for Monitoring Degeneration in Duchenne Muscular Dystrophy". This is a pilot clinical trial to assess the ability of a new ultrasound-based imaging method, Double-Push Acoustic Radiation Force (DP ARF) ultrasound, to monitor the progression of Duchenne muscular dystrophy. The hypothesis being tested is that DP ARF ultrasound delineates changes in muscle compo...
What is the current status of trial NCT01506518?
This trial is currently completed. The enrollment target is 60 participants. The study started on 2012-01. Estimated completion is 2020-05-31.
Who is sponsoring clinical trial NCT01506518?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.